Atlas Trials

High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study

Clinical trial NCT02169882 · COMPLETED

Trial details

NCT number
NCT02169882
Sponsor
Universitas Padjadjaran
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Tuberculosis, Meningeal
Start date
2014-12-01
Primary completion
2016-11-05
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.